nach oben

memo - Magazine of European Medical Oncology

Erschienen in:

21.02.2019 | educational

Educational no.5: next-generation gene panel sequencing

verfasst von: Wolfgang Kranewitter

Erschienen in: memo - Magazine of European Medical Oncology | Ausgabe 2/2019

Einloggen, um Zugang zu erhalten

Summary

Next-generation sequencing allows the simultaneous interrogation of a large number of genomic targets and is therefore highly suitable for situations, in which mutations in many different genes may have a clinical impact. This short educational discusses the process from the sample to the reported mutations and the limits of the method.

Vorheriger Artikel memo—publisher’s report 2018

Nächster Artikel Direct oral anticoagulants: a treatment option in oncological patients

Richards S, Aziz N, Bale S, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 2015;17(5):405–24.CrossRef

Li MM, Datto M, Duncavage EJ, et al. Standards and guidelines for the interpretation and reporting of sequence variants in Cancer: a joint consensus recommendation of the Association for Molecular Pathology, American Society of Clinical Oncology, and College of American Pathologists. J Mol Diagn. 2017;19(1):4–23.CrossRef

Ståhlberg A, Krzyzanowski PM, Egyud M, Filges S, Stein L, Godfrey TE. Simple multiplexed PCR-based barcoding of DNA for ultrasensitive mutation detection by next-generation sequencing. Nat Protoc. 2017;12(4):664–82.CrossRef

Le Gallo M, Lozy F, Bell DW. Next-generation sequencing. Adv Exp Med Biol. 2017;943:119–48.CrossRef

Yohe S, Thyagarajan B. Review of clinical next-generation sequencing. Arch Pathol Lab Med. 2017;141(11):1544–57.CrossRef

Titel: Educational no.5: next-generation gene panel sequencing
verfasst von: Wolfgang Kranewitter
Publikationsdatum: 21.02.2019
Verlag: Springer Vienna
Erschienen in: memo - Magazine of European Medical Oncology / Ausgabe 2/2019
Print ISSN: 1865-5041
Elektronische ISSN: 1865-5076
DOI: https://doi.org/10.1007/s12254-019-0479-4

Springer Medizin Österreich

Summary

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 2/2019

Saving lives with lung cancer screening

Obituary for Professor Michael Steurer

Resistance to chemotherapy and anti-angiogenic therapy in ovarian cancer

Overcoming resistance and bypassing checkpoints—possible new therapeutic frontiers in oncology

Lung cancer screening—the surgeon’s perspective

Whom to screen? A view on lung cancer screening from the pneumologist’s perspective